Dow Up 0.51% Nasdaq Up 0.24%

NovaBay Pharmaceuticals, Inc. (NBY)

-NYSE MKT
0.72 Down 0.01(1.37%) Nov 21, 4:00PM EST
Prev Close:0.73
Open:0.74
Bid:0.70 x 1800
Ask:0.77 x 500
1y Target Est:1.45
Beta:0.37
Next Earnings Date:N/A
Day's Range:0.71 - 0.74
52wk Range:0.69 - 1.48
Volume:94,230
Avg Vol (3m):194,675
Market Cap:37.17M
P/E (ttm):N/A
EPS (ttm):-0.32
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NBY

Comparison

Symbol% ChgMkt Cap
NBYDown 1.37%37.17M
ABTUp 0.07%65.97B
PFEUp 0.03%191.86B
SNNUp 0.79%15.46B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):35.12
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.29
Quarterly EPS Est (Dec-14) :-0.08
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NovaBay Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing product candidates for the therapeutic needs of anti-infective market. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback